The atherectomy devices market is expected to reach USD 0.72 billion by 2032 at 11.9% CAGR during the forecast period 2023-2032.
The global Atherectomy Devices Market has been witnessing significant growth, driven by advancements in medical technology and the increasing prevalence of cardiovascular diseases. Atherectomy is a minimally invasive procedure designed to remove atherosclerotic plaques from blood vessels, restoring proper blood flow and preventing potential complications.
One of the key players in this market is the laser atherectomy segment. Laser atherectomy involves the use of laser energy to vaporize or ablate atherosclerotic plaques, offering a precise and effective solution for plaque removal. The technology has gained traction due to its ability to target specific lesions and minimize damage to surrounding healthy tissue. Laser atherectomy devices have become an essential tool in the armamentarium of interventional cardiologists and vascular surgeons.
Another crucial component of the Atherectomy Devices Market is rotational atherectomy. This technique utilizes a high-speed rotational burr to physically abrade and remove the plaque from the arterial walls. Rotational atherectomy is particularly useful in cases where the plaque is calcified and resistant to other forms of treatment. The procedure allows for precise control and customization, making it a valuable option for complex lesions.
The market is witnessing a surge in demand for these advanced atherectomy devices as they offer a less invasive alternative to traditional open surgeries. Patients benefit from reduced recovery times and lower risks of complications, driving the adoption of these innovative technologies.
Major Key Players:
Notable Atherectomy Devices Companies include Cardinal Health, Straub Medical, Koninklijke Philips, B. Braun Melsungen AG, Boston Scientific Corporation, Minnetronix, Inc., Avinger, Biotronik, Abbott, C.R. Bard, Biomerics, and others. Industry players have adopted strategies such as strategic alliances, extensive research, and development activities, joint ventures, collaborations, and new product launches to stay ahead in the competition.
Segment Analysis
The Market Research Future Report provides an inclusive segmental analysis of the global atherectomy devices market based on application, product type, and end user.
By product type, the atherectomy devices market is segmented into rotational atherectomy systems, photo-ablative atherectomy systems, orbital atherectomy systems, directional atherectomy systems, and others. Rotational atherectomy systems allow percutaneous coronary intervention, especially for calcified coronary lesions that are complex. It functions on the differential cutting principle and preferentially ablates inelastic, hard, calcified plaque. The photo-ablative atherectomy systems help in vaporizing the plaque. The orbital atherectomy system helps to continuously clear plaque by pulverizing into small particles. The directional atherectomy system helps to remove the plaque by cutting through one direction. Of these, directional atherectomy systems will lead the market over the forecast period.
By application, the global atherectomy devices market is segmented into peripheral atherectomy devices, vascular, neurovascular, cardiovascular, and others. Of these, the peripheral vascular segment will dominate the market over the forecast period.
By end user, the global atherectomy devices market is segmented into ambulatory surgery centers, hospitals, and others. Of these, hospitals is likely to have a major share in the market over the forecast period.
Regional Analysis
The Americas holds the dominant share in the global atherectomy devices market, followed by Europe. The growing prevalence of atherosclerosis in North America is likely to ensure continued dominance of the Americas in the global atherectomy devices market over the forecast period.
Recent Development
Sep 2023 A study on Abbott's Healthy Food Rx, a food as medicine initiative that offers medical prescriptions for nutritious foods to be delivered to patients' homes to manage their diabetes, revealed clinically significant benefits for those with the disease. In a real-world study, participants in Healthy Food Rx had lower A1C levels, better diabetes self-management, and improved overall diet quality and food security over 12 months. The study was carried out by the Public Health Institute's Center for Wellness and Nutrition (PHI CWN) in an operational community clinic.
Nov 2023 To give surgical teams safe and practical instrument access in the operating room, Cardinal Health announced the launch of their SmartGown EDGE Breathable Surgical Gown with ASSISTTM Instrument Pockets in the United States. The robe, which is only offered by Cardinal Health, contains one suggested instrument in each pocket during surgical procedures, assisting with handling efficiency and freeing up healthcare teams to concentrate on providing safe patient care. While operating in intricate sterile fields, surgeons and doctors can easily access frequently used surgical instruments* thanks to the chest pockets built into the SmartGown EDGE. Because of its distinctive pocket shape, the robe reduces the chance of contamination and accidental tool drops outside of the sterile region. Surgical teams can decrease the number of instrument handoffs or swaps during surgery by storing frequently used instruments* in the pockets of the SmartGown EDGE. This feature also promotes possible time savings and self-sufficiency.
Browse Related Reports:
Artificial Intelligence in Healthcare Market
Medical Billing Outsourcing Market
Artificial Intelligence in Drug Discovery Market
For More Information, Please Visit @ Market Research Future
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek